The gracefully aging immune system

Science Translational Medicine

Volumn 5, Issue 185, 2013, Pages

  Boraschi, Diana ^a   Aguado, M Teresa ^b   Dutel, Catherine ^c   Goronzy, Jörg ^d   Louis, Jacques ^c   Grubeck Loebenstein, Beatrix ^e   Rappuoli, Rino ^f   Del Giudice, Giuseppe ^f  

^a CNR   (Italy)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c Fondation Mérieux Applied Research   (France)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF INNSBRUCK   (Austria)

^f NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AS 03; CD4 ANTIGEN; CD8 ANTIGEN; DUAL SPECIFICITY PHOSPHATASE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; IMMUNOLOGICAL ADJUVANT; INFLUENZA VACCINE; MIFAMURTIDE; MITOGEN ACTIVATED PROTEIN KINASE; PNEUMOCOCCUS VACCINE; STRESS ACTIVATED PROTEIN KINASE; TETANUS TOXOID; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VARICELLA ZOSTER VACCINE;

AGED; AGING; ANTIGEN PRESENTING CELL; APOPTOSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOMETRY; DRUG EFFICACY; ELDERLY CARE; EXERCISE; FRAIL ELDERLY; HERPES ZOSTER; HUMAN; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOCOMPETENCE; IMMUNOLOGICAL MEMORY; INDIVIDUALIZATION; INFECTION PREVENTION; INFECTION RESISTANCE; INFECTION SENSITIVITY; INFLAMMATION; INFLUENZA; INNATE IMMUNITY; ITALY; LIFE EXPECTANCY; MALNUTRITION; MASS SPECTROMETRY; MEDICAL RESEARCH; METABOLIC RATE; MORBIDITY; NARCOLEPSY; OXIDATIVE STRESS; PNEUMONIA; PRIORITY JOURNAL; PROPHYLAXIS; PROTEOMICS; RECEPTOR UPREGULATION; REVIEW; SYSTEMS BIOLOGY; TETANUS; TIME OF FLIGHT MASS SPECTROMETRY; TREATMENT RESPONSE;

AGED; AGING; COMMUNICABLE DISEASES; HUMANS; IMMUNE SYSTEM; IMMUNITY; TREATMENT OUTCOME; VACCINES;

EID: 84878316328     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3005624     Document Type: Review

References (67)

1. D. Boraschi, G. Del Giudice, C. Dutel, B. Ivanoff, R. Rappuoli, B. Grubeck-Loebenstein, Ageing and immunity: Addressing immune senescence to ensure healthy ageing. Vaccine 28, 3627-3631 (2010).
2. L. Flicker, K. A. McCaul, G. J. Hankey, K. Jamrozik, W. J. Brown, J. E. Byles, O. P. Almeida, Body mass index and survival in men and women aged 70 to 75. J. Am. Geriatr. Soc. 58, 234-241 (2010).
3. T. Yoneyama, M. Yoshida, T. Matsui, H. Sasaki, Oral Care Working Group, Oral care and pneumonia. Lancet 354, 515 (1999).
4. A. Panda, A. Arjona, E. Sapey, F. Bai, E. Fikrig, R. R. Montgomery, J. M. Lord, A. C. Shaw, Human innate immunosenescence: Causes and consequences for immunity in old age. Trends Immunol. 30, 325-333 (2009).
5. A. C. Shaw, S. Joshi, H. Greenwood, A. Panda, J. M. Lord, Aging of the innate immune system. Curr. Opin. Immunol. 22, 507-513 (2010).
6. C. R. Gomez, E. D. Boehmer, E. J. Kovacs, The aging innate immune system. Curr. Opin. Immunol. 17, 457-462 (2005).
7. T. Fulop, A. Larbi, N. Douziech, C. Fortin, K. P. Guérard, O. Lesur, A. Khalil, G. Dupuis, Signal transduction and functional changes in neutrophils with aging. Aging Cell 3, 217-226 (2004).
8. A. Panda, F. Qian, S. Mohanty, D. van Duin, F. K. Newman, L. Zhang, S. Chen, V. Towle, R. B. Belshe, E. Fikrig, H. G. Allore, R. R. Montgomery, A. C. Shaw, Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response. J. Immunol. 184, 2518-2527 (2010).
9. C. Franceschi, Inflammaging as a major characteristic of old people: Can it be prevented or cured? Nutr. Rev. 65, S173-S176 (2007).
10. A. Agrawal, A. Sridharan, S. Prakash, H. Agrawal, Dendritic cells and aging: Consequences for autoimmunity. Expert Rev. Clin. Immunol. 8, 73-80 (2012).
11. S. Park, S. Kang, K. H. Min, K. Woo Hwang, H. Min, Age-associated changes in microRNA expression in bone marrow derived dendritic cells. Immunol. Invest. 42, 179-190 (2013).
12. D. van Duin, H. G. Allore, S. Mohanty, S. Ginter, F. K. Newman, R. B. Belshe, R. Medzhitov, A. C. Shaw, Prevaccine determination of the expression of costimulatory B7 molecules in activated monocytes predicts influenza vaccine responses in young and older adults. J. Infect. Dis. 195, 1590-1597 (2007).
13. J. Nikolich-Zugich, Ageing and life-long maintenance of T-cell subsets in the face of latent persistent infections. Nat. Rev. Immunol. 8, 512-522 (2008).
14. J. Nikolich-Zugich, B. D. Rudd, Immune memory and aging: An infinite or finite resource? Curr. Opin. Immunol. 22, 535-540 (2010).
15. G. Li, M. Yu, W.-W. Lee, M. Tsang, E. Krishnan, C. M. Weyand, J. J. Goronzy, Decline in miR-181a expression with age impairs T cell receptor sensitivity by increasing DUSP6 activity. Nat. Med. 18, 1518-1524 (2012).
16. M. Yu, G. Li, W.-W. Lee, M. Yuan, D. Cui, C. M. Weyand, J. J. Goronzy, Signal inhibition by the dual-specific phosphatase 4 impairs T cell-dependent B-cell responses with age. Proc. Natl. Acad. Sci. U.S.A. 109, E879-E888 (2012).
17. S. Brunner, D. Herndler-Brandstetter, C. R. Arnold, G. J. Wiegers, A. Villunger, M. Hackl, J. Grillari, M. Moreno-Villanueva, A. Bürkle, B. Grubeck-Loebenstein, Upregulation of miR-24 is associated with a decreased DNA damage response upon etoposide treatment in highly differentiated CD8(+) T cells sensitizing them to apoptotic cell death. Aging Cell 11, 579-587 (2012).
18. D. Herndler-Brandstetter, K. Landgraf, A. Tzankov, B. Jenewein, R. Brunauer, G. T. Laschober, W. Parson, F. Kloss, R. Gassner, G. Lepperdinger, B. Grubeck-Loebenstein, The impact of aging on memory T cell phenotype and function in the human bone marrow. J. Leukoc. Biol. 91, 197-205 (2012).
19. M. M. Cavanagh, C. M. Weyand, J. J. Goronzy, Chronic inflammation and aging: DNA damage tips the balance. Curr. Opin. Immunol. 24, 488-493 (2012).
20. R. J. Hodes, K. S. Hathcock, N. P. Weng, Telomeres in T and B cells. Nat. Rev. Immunol. 2, 699-706 (2002).
21. S. T. Parish, S. Kim, R. K. Sekhon, J. E. Wu, Y. Kawakatsu, R. B. Effros, Adenosine deaminase modulation of telomerase activity and replicative senescence in human CD8 T lymphocytes. J. Immunol. 184, 2847-2854 (2010).
22. H. Fujii, L. Shao, I. Colmegna, J. J. Goronzy, C. M. Weyand, Telomerase insufficiency in rheumatoid arthritis. Proc. Natl. Acad. Sci. U.S.A. 106, 4360-4365 (2009).
23. L. Shao, H. Fujii, I. Colmegna, H. Oishi, J. J. Goronzy, C. M. Weyand, Deficiency of the DNA repair enzyme ATM in rheumatoid arthritis. J. Exp. Med. 206, 1435-1449 (2009).
24. + T cells during aging. J. Exp. Med. 206, 1929-1940 (2009).
25. + T cell accumulation during a human cutaneous antigenspecific memory response in vivo. J. Clin. Invest. 118, 3639-3650 (2008).
26. + regulatory T cells induce alternative activation of human monocytes/macrophages. Proc. Natl. Acad. Sci. U.S.A. 104, 19446-19451 (2007).
27. K. L. Gibson, Y.-C. Wu, Y. Barnett, O. Duggan, R. Vaughan, E. Kondeatis, B.-O. Nilsson, A. Wikby, D. Kipling, D. K. Dunn-Walters, B-cell diversity decreases in old age and is correlated with poor health status. Aging Cell 8, 18-25 (2009).
28. Y. C. Wu, D. Kipling, D. K. Dunn-Walters, Age-related changes in human peripheral blood IgH repertoire following vaccination. Front Immunol. 3, 193 (2012).
29. M. L. Kohut, B. A. Arntson, W. Lee, K. Rozeboom, K.-J. Yoon, J. E. Cunnick, J. McElhaney, Moderate exercise improves antibody response to influenza immunization in older adults. Vaccine 22, 2298-2306 (2004).
30. R. F. Pass, C. Zhang, A. Evans, T. Simpson, W. Andrews, M. L. Huang, L. Corey, J. Hill, E. Davis, C. Flanigan, G. Cloud, Vaccine prevention of maternal cytomegalovirus infection. N. Engl. J. Med. 360, 1191-1199 (2009).
31. G. Galli, K. Hancock, K. Hoschler, J. DeVos, M. Praus, M. Bardelli, C. Malzone, F. Castellino, C. Gentile, T. McNally, G. Del Giudice, A. Banzhoff, V. Brauer, E. Montomoli, M. Zambon, J. Katz, K. Nicholson, I. Stephenson, Fast rise of broadly cross-reactive antibodies after boosting longlived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine. Proc. Natl. Acad. Sci. U.S.A. 106, 7962-7967 (2009).
32. S. G. Deeks, E. Verdin, J. M. McCune, Immunosenescence and HIV. Curr. Opin. Immunol. 24, 501-506 (2012).
33. G. Foglia, S. Shah, C. Luxemburger, P. J. Pietrobon, Clostridium dif cile: Development of a novel candidate vaccine. Vaccine 30, 4307-4309 (2012).
34. B. Weinberger, B. Grubeck-Loebenstein, Vaccines for the elderly. Clin. Microbiol. Infect. 18, (suppl. 5), 100-108 (2012).
35. R. Arnou, G. Icardi, M. De Decker, A. Ambrozaitis, M. P. Kazek, F. Weber, P. Van Damme, Intradermal influenza vaccine for older adults: A randomized controlled multicenter phase III study. Vaccine 27, 7304-7312 (2009).
36. C. Loucoubar, R. Paul, A. Bar-Hen, A. Huret, A. Tall, C. Sokhna, J. F. Trape, A. B. Ly, J. Faye, A. Badiane, G. Diakhaby, F. D. Sarr, A. Diop, A. Sakuntabhai, J. F. Bureau, An exhaustive, non-euclidean, non-parametric data mining tool for unraveling the complexity of biological systems - Novel insights into malaria. PLoS ONE 6, e24085 (2011).
37. S. Oncü, M. Önde, S. Oncü, F. Ergin, B. Oztürk, Tetanus seroepidemiology and factors influencing immunity status among farmers of advanced age. Health Policy 100, 305-309 (2011).
38. Centers for Disease Control and Prevention (CDC), Tetanus surveillance United States, 2001-2008. MMWR Morb. Mortal. Wkly. Rep. 60, 365-369 (2011).
39. D. T. O'Hagan, R. Rappuoli, E. De Gregorio, T. Tsai, G. Del Giudice, MF59 adjuvant: The best insurance against influenza strain diversity. Expert Rev. Vaccines 10, 447-462 (2011).
40. G. Del Giudice, R. Rappuoli, in Immunosenescence, A. Thiel, Ed. (Birkhaeuser, Basel, 2012) pp. 201-227.
41. A. Szakács, N. Darin, T. Hallböök, Increased childhood incidence of narcolepsy in western Sweden after H1N1 influenza vaccination. Neurology 80, 1315-1321 (2013).
42. H. Nohynek, J. Jokinen, M. Partinen, O. Vaarala, T. Kirjavainen, J. Sundman, S. L. Himanen, C. Hublin, I. Julkunen, P. Olsén, O. Saarenpää-Heikkilä, T. Kilpi, AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS ONE 7, e33536 (2012).
43. E. Miller, N. Andrews, L. Stellitano, J. Stowe, A. M. Winstone, J. Shneerson, C. Verity, Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis. BMJ 346, (feb26 2), f794 (2013).
44. F. Han, L. Lin, S. C. Warby, J. Faraco, J. Li, S. X. Dong, P. An, L. Zhao, L. H. Wang, Q. Y. Li, H. Yan, Z. C. Gao, Y. Yuan, K. P. Strohl, E. Mignot, Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Ann. Neurol. 70, 410-417 (2011).
45. S. C. Bendall, E. F. Simonds, P. Qiu, A. D. Amir, P. O. Krutzik, R. Finck, R. V. Bruggner, R. Melamed, A. Trejo, O. I. Ornatsky, R. S. Balderas, S. K. Plevritis, K. Sachs, D. Pe'er, S. D. Tanner, G. P. Nolan, Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science 332, 687-696 (2011).
46. E. W. Newell, N. Sigal, S. C. Bendall, G. P. Nolan, M. M. Davis, Cytometry by time-of-flight shows combinatorial cytokine expression and virus-specific cell niches within a continuum of CD8+ T cell phenotypes. Immunity 36, 142-152 (2012).
47. P. Qiu, E. F. Simonds, S. C. Bendall, K. D. Gibbs, Jr, R. V. Bruggner, M. D. Linderman, K. Sachs, G. P. Nolan, S. K. Plevritis, Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE. Nat. Biotechnol. 29, 886-891 (2011).
48. S. C. Bendall, G. P. Nolan, M. Roederer, P. K. Chattopadhyay, A deep profiler's guide to cytometry. Trends Immunol. 33, 323-332 (2012).
49. A. Bernstein, B. Pulendran, R. Rappuoli, Systems vaccinomics: The road ahead for vaccinology. OMICS 15, 529-531 (2011).
50. T. D. Querec, R. S. Akondy, E. K. Lee, W. Cao, H. I. Nakaya, D. Teuwen, A. Pirani, K. Gernert, J. Deng, B. Marzolf, K. Kennedy, H. Wu, S. Bennouna, H. Oluoch, J. Miller, R. Z. Vencio, M. Mulligan, A. Aderem, R. Ahmed, B. Pulendran, Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat. Immunol. 10, 116-125 (2009).
51. S. S. Duraisingham, N. Rouphael, M. M. Cavanagh, H. I. Nakaya, J. J. Goronzy, B. Pulendran, Systems biology of vaccination in the elderly. Curr. Top. Microbiol. Immunol. 363, 117-142 (2013).
52. R. Banchereau, A. Jordan-Villegas, M. Ardura, A. Mejias, N. Baldwin, H. Xu, E. Saye, J. Rossello-Urgell, P. Nguyen, D. Blankenship, C. B. Creech, V. Pascual, J. Banchereau, D. Chaussabel, O. Ramilo, Host immune transcriptional profiles reflect the variability in clinical disease manifestations in patients with Staphylococcus aureus infections. PLoS ONE 7, e34390 (2012).
53. A. C. Logan, H. Gao, C. Wang, B. Sahaf, C. D. Jones, E. L. Marshall, I. Buño, R. Armstrong, A. Z. Fire, K. I. Weinberg, M. Mindrinos, J. L. Zehnder, S. D. Boyd, W. Xiao, R. W. Davis, D. B. Miklos, High-throughput VDJ sequencing for quantification of minimal residual disease in chronic lymphocytic leukemia and immune reconstitution assessment. Proc. Natl. Acad. Sci. U.S.A. 108, 21194-21199 (2011).
54. I. den Braber, T. Mugwagwa, N. Vrisekoop, L. Westera, R. Mögling, A. B. de Boer, N. Willems, E. H. Schrijver, G. Spierenburg, K. Gaiser, E. Mul, S. A. Otto, A. F. Ruiter, M. T. Ackermans, F. Miedema, J. A. Borghans, R. J. de Boer, K. Tesselaar, Maintenance of peripheral naive T cells is sustained by thymus output in mice but not humans. Immunity 36, 288-297 (2012).
55. P. L. Johnson, A. J. Yates, J. J. Goronzy, R. Antia, Peripheral selection rather than thymic involution explains sudden contraction in naive CD4 T-cell diversity with age. Proc. Natl. Acad. Sci. U.S.A. 109, 21432-21437 (2012).
56. D. N. Posnett, R. Sinha, S. Kabak, C. Russo, Clonal populations of T cells in normal elderly humans: The T cell equivalent to "benign monoclonal gammapathy." J. Exp. Med. 179, 609-618 (1994).
57. I. Messaoudi, J. Warner, J. Nikolich-Zugich, Age-related CD8+ T cell clonal expansions express elevated levels of CD122 and CD127 and display defects in perceiving homeostatic signals. J. Immunol. 177, 2784-2792 (2006).
58. N. Khan, N. Shariff, M. Cobbold, R. Bruton, J. A. Ainsworth, A. J. Sinclair, L. Nayak, P. A. Moss, Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J. Immunol. 169, 1984-1992 (2002).
59. J. J. Goronzy, C. M. Weyand, T cell development and receptor diversity during aging. Curr. Opin. Immunol. 17, 468-475 (2005).
60. C. E. Zielinski, D. Corti, F. Mele, D. Pinto, A. Lanzavecchia, F. Sallusto, Dissecting the human immunologic memory for pathogens. Immunol. Rev. 240, 40-51 (2011).
61. X. S. He, S. Sasaki, C. F. Narvaez, C. Zhang, H. Liu, J. C. Woo, G. W. Kemble, C. L. Dekker, M. M. Davis, H. B. Greenberg, Plasmablast-derived polyclonal antibody response after influenza vaccination. J. Immunol. Methods 365, 67-75 (2011).
62. S. Sasaki, M. Sullivan, C. F. Narvaez, T. H. Holmes, D. Furman, N. Y. Zheng, M. Nishtala, J. Wrammert, K. Smith, J. A. James, C. L. Dekker, M. M. Davis, P. C. Wilson, H. B. Greenberg, X. S. He, Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies. J. Clin. Invest. 121, 3109-3119 (2011).
63. L. J. Scott, M. Sanford, Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed): A guide to its use in older adults. Drugs Aging 29, 847-855 (2012).
64. M. N. Oxman, Zoster vaccine: Current status and future prospects. Clin. Infect. Dis. 51, 197-213 (2010).
65. J. N. Vermeulen, J. M. Lange, S. K. Tyring, P. H. Peters, M. Nunez, G. Poland, M. J. Levin, C. Freeman, I. Chalikonda, J. Li, J. G. Smith, M. J. Caulfield, J. E. Stek, I. S. Chan, R. Vessey, F. P. Schödel, P. W. Annunziato, K. Schlienger, J. L. Silber, Safety, tolerability, and immunogenicity after 1 and 2 doses of zoster vaccine in healthy adults ≥60 years of age. Vaccine 30, 904-910 (2012).
66. R. Rappuoli, C. W. Mandl, S. Black, E. De Gregorio, Vaccines for the twenty-first century society. Nat. Rev. Immunol. 11, 865-872 (2011).
67. R. Rappuoli, D. Medaglini, ADITEC: Joining forces for next-generation vaccines. Sci. Transl. Med. 4, 128cm4 (2012).